The European Court of Justice is faced with a crucial decision on stem cell research. Justin Turner QC explains.
When, in the course of case G2/06 (the WARF application), the Enlarged Board of Appeal of the European Patent Office (EPO) was invited to seek the assistance of the Court of Justice (the court) in construing Article 6 of the Biotechnology Directive, it must have come as no surprise to observers that it declined this invitation. The enlarged board was not persuaded by the potential awkwardness of the court subsequently reaching an alternative view as to the patentability of embryonic stem cell lines.
We might shortly find out what effect contrary rulings of these parallel institutions will have. The court is to rule on certain questions relating to the patentability of embryonic stem cells in C34/10 (Brüstle v. Greenpeace). The enlarged board has already ruled that certain embryonic stem cell lines are not patentable. Its decision, which in practice may be of limited scope, is almost certainly wrong.
Article 6(1) of the Biotechnology Directive provides that inventions shall be considered to be unpatentable where their commercial exploitation would be contrary to ordre public or morality. It continues in 6(2):
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Stem cell research, stem cells, EPO, ECJ, Brüstle v. Greenpeace
